AZ and GSK Dip Into Diagnostics To Support COVID-19 UK Tests
Also Lending Expertise In Automation And Robotics
The pharma giants are joining forces to help the UK reach its ambitious target of testing 100,000 people a day for coronavirus by the end of April.
You may also be interested in...
Vir began pursuing immunological approaches to infectious diseases three years before its COVID-19 work. Its hepatitis B, flu and HIV clinical trials are delayed about six months due to coronavirus-related issues.
Big pharma’s consumer division launches partnership with tech company Luminostics.
AstraZeneca will launch a global clinical trial for its blood cancer drug Calquence because it showed early respiratory promise in later-stage COVID-19 patients, those in intensive care units and on ventilators.